文献速递前列腺增生与排尿功能障碍泌尿系感染

全植入镍大小胫神经刺激器治疗膀胱过度活动症伴急迫性尿失禁的12个月耐久性:单臂前瞻性研究

Twelve-month Durability of a Fully-implanted, Nickel-sized and Shaped Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome with Urgency Urinary Incontinence: A Single-Arm, Prospective Study.
PubMed 文献 · Urology · 2021-05-26

本研究评估eCoin(镍大小、原电池供电、经20分钟局麻手术植入小腿的神经调控设备)治疗难治性急迫性尿失禁的安全性和有效性。

要点

  • eCoin植入12个月时65%患者急迫性尿失禁发作减少≥50%,26%完全控尿。
  • 每日急迫性尿失禁发作中位数从基线4.2次降至12个月时1.7次。

核心结论

  • eCoin是治疗膀胱过度活动症相关急迫性尿失禁的安全有效方法,可显著减少或完全缓解症状且无显著安全性担忧。

研究设计与样本

  • 前瞻性、单臂、开放标签可行性临床试验,在美国和新西兰7个中心开展,共纳入46例难治性急迫性尿失禁受试者。
  • 受试者经20分钟局麻手术在小腿胫神经上方植入eCoin,4周后激活,于激活后3、6、12个月收集膀胱日记和验证性生活质量量表并与基线比较。

主要发现

  • 应答者定义为急迫性尿失禁发作减少≥50%,12个月时65%受试者为应答者,26%达到完全控尿。
  • 每日急迫性尿失禁发作中位数从基线4.2次降至12个月时1.7次。
  • 1例受试者发生相关严重不良事件。

关键数值与推荐

  • 应答标准:急迫性尿失禁发作较基线减少≥50%。

临床怎么用

  • 对于难治性急迫性尿失禁患者,可考虑eCoin胫神经刺激作为局麻下20分钟植入的微创神经调控选择。
  • 术后4周激活并随访膀胱日记及生活质量,按≥50%发作减少评估应答,12个月时约三分之二患者可获益。

局限性

  • 单臂、开放标签设计,无对照,样本量46例,可行性研究结果需更大规模对照研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate the safety and efficacy of the eCoin - a nickel-sized, primary battery-powered, neuromodulation device for the treatment of urgency urinary incontinence which is implanted in the lower leg in a 20-minute procedure under local anesthesia. A feasibility clinical trial was conducted and the results after 1 year of treatment with the eCoin are presented. METHODS: A total of 46 participants with refractory urgency urinary incontinence were included in this prospective, single-arm, open-label study. This study was conducted at 7 sites in the United States and New Zealand. Participants in this study were implanted with the eCoin in the lower leg over the tibial nerve and activated after 4 weeks. Bladder diary data and validated quality-of-life instruments, collected at 3, 6, and 12 months' post-activation, were compared to baseline values. RESULTS: Responders were defined as those who had a ≥50% reduction in reported episodes of urgency urinary incontinence. At 12 months', 65% of participants were considered responders with 26% of participants achieving complete continence. The median number of urgency urinary incontinence episodes per day decreased from 4.2 at baseline to 1.7 at 12 months'. Seventy percent of participants reported feeling "better", "much better", or "very much better" on the Likert 7-point maximum scale. One participant experienced a related serious adverse event. CONCLUSION: The eCoin is a safe and effective treatment for urgency urinary incontinence associated with overactive bladder syndrome, with significant reduction or complete resolution of symptoms and no significant safety concerns.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Gilling P, Meffan P, Kaaki B, et al. Twelve-month Durability of a Fully-implanted, Nickel-sized and Shaped Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome with Urgency Urinary Incontinence: A Single-Arm, Prospective Study. Urology. 2021. PMID: 34048826. doi:10.1016/j.urology.2021.04.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。